Skip to main content
Log in

Cervical lymphadenopathy: study of 251 patients

  • Miscellaneous
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Correct diagnosis of cervical lymphadenopathy is often a great challenge. The objective of this case study is to describe the distribution of the most common causes of unclear neck swellings presented in an ENT-Department and to evaluate the clinical history, examination and laboratory findings. In a retrospective study at the Department of Otorhinolaryngology, University Medical Center Homburg/Saar, 251 patients were enrolled with clinical and ultrasound signs of cervical lymphadenopathy as well as lymph node extirpation for histopathological evaluation. 127 patients (50.6 %) had a histological malignant finding. The distribution of the most common pathological conditions was as follows: Non-specific reactive hyperplasia n = 89 (35.5 %), metastases n = 86 (34.3 %), lymphoma n = 41 (16.3 %), granulomatous lesions n = 15 (6 %), abscess formations n = 5 (2 %), necrotic lymphadenitis and Castleman’s disease one case of each, lymph node with normal architecture n = 7 (2.8 %), and neck masses mimicking lymphadenopathy n = 6 cases (2.4 %). The following factors identified by multivariate logistic regression were significantly associated to malignant lymphadenopathy: increasing age, generalized lymphadenopathy and history of malignant disorder, fixed neck masses and increasing diameter in ENT examination, bulky lesion, absence of hilus, blurred outer contour, protective role of the long form and decreasing Solbiati-index values by ultrasound B-Mode gray scale examination. Level II contained more benign lymphatic lesions, while the malignancy rate in level IV and V was enhanced. Laboratory parameters significantly associated to malignancies were CRP, LDH and thrombocytopenia. Patients with persisting cervical lymphadenopathy and over 3 weeks of antibiotic treatment should be considered for early biopsy, especially if some of the risk factors, pointed out in this study, are present.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Parisi E, Glick M (2005) Cervical lymphadenopathy in the dental patient: a review of clinical approach. Quintessence Int 36:423–436

    PubMed  Google Scholar 

  2. Nield L, Kamat D (2004) Lymphadenopathy in children: when and how to evaluate. Clin Pediatr 43:25–33

    Article  Google Scholar 

  3. Leung A, Robson W (2004) Childhood cervical lymphadenopathy. J Pediatr Health Care 18:3–7

    Article  PubMed  Google Scholar 

  4. Fitjen GH, Blijham GH (1988) Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians’ workup. J Fam Prac 2:373–376

    Google Scholar 

  5. Kelly C, Kelly RJ (1998) Lymphadenopathy in children. Pediatr Clin North Am 45:875–888

    Article  CAS  PubMed  Google Scholar 

  6. Lee Y, Terry R, Lukes R (1980) Lymph node biopsy for diagnosis: a statistical study. J Surg Oncol 14:53–60

    Article  CAS  PubMed  Google Scholar 

  7. Atula T, Varpula M, Kurki T, Klemi P, Grénman R (1997) Assessment of cervical lymph node status in head and neck cancer patients: palpation, computed tomography and low field magnetic resonance imaging compared with ultrasound-guided fine-needle aspiration cytology. Eur J Radiol 25:152–161

    Article  CAS  PubMed  Google Scholar 

  8. Abba AA, Bamboye AE, Afzal M, Rahmatullah R (2002) Lymphadenopathy in adults. A clinicopathological analysis. Saudi Med J 23:282–286

    PubMed  Google Scholar 

  9. Balm A, van Velthuysen M, Hoebers F (2010) Diagnosis and treatment of a neck node swelling suspicious for a malignancy: an algoritmic approach. Int J Surg Oncol 2010:581540

    PubMed Central  CAS  PubMed  Google Scholar 

  10. Johansen JBS (2008) Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck form an unknown primary tumor. Results from the Dahanca-13 study. Head Neck 30:471–478

    Article  PubMed  Google Scholar 

  11. Wartski M, Stanc E, Gontier E (2007) In search of primary unknown tumor presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 28:365–371

    Article  PubMed  Google Scholar 

  12. Miller F, Karnad A, Eng T, Hussey D, McGuff H, Otto R (2008) Management of the unknown primary carcinoma : long-term follow-up on a negative PET-scan and panendoscopy. Head Neck 30:28–34

    Article  PubMed  Google Scholar 

  13. Cerci JJ, Trindade E, Buccheri V, Fanti S, Coutinho AM, Zanoni L, Linardi CC, Celli M, Delbeke D, Pracchia LF, Pitela FA, Soares J Jr, Zinzani PL, Meneghetti JC (2011) Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions. Clin Lymphoma Myeloma Leuk 11(4):314–320

    Article  PubMed  Google Scholar 

  14. Chau I, Kelleher M, Cunningham D et al (2003) Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer 88:354–361

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Steel B, Schwartz M, Ramzy I (1995) Fine needle aspiration biopsy in the diagnosis of lymphadenopathy in 1,103 patients. Role, limitations and analysis of diagnostic pitfalls. Acta Cytol 39:76–81

    CAS  PubMed  Google Scholar 

  16. Nasuti J, Yu G, Boudousquie A, Gupta P (2000) Diagnostic value of lymph node fine needle aspiration cytology : an institutional experience of 387 cases observed over a 5-year period. Cytopathology 11:18–31

    Article  CAS  PubMed  Google Scholar 

  17. Moore S, Schneider J, Schaaf H (2003) Diagnostic aspects of cervical lymphadenopathy in children. Pediatr Surg Int 19:240–244

    Article  CAS  PubMed  Google Scholar 

  18. Schafernak K, Kluskens L, Ariga R, Reddy V, Galtuso P (2003) Fine-needle aspiration of superficial and deeply seated lymph nodes on patients with and without a history of malignancy: review of 439 cases. Diagn Cytopatho 29:315–319

    Article  Google Scholar 

  19. Nolder AR (2013) Paediatric cervical lymphadenopathy, when to biopsy? Curr Opin Otolaryngol Head Neck Surg 21(6):567–570

    PubMed  Google Scholar 

  20. McHenry C, Cooney M, Slusarczyk S, Khiyami A (1999) Supraclavicular lymphadenopathy: the spectrum of pathology and evaluation by fine-needle aspiration biopsy. Am Surg 65:742–746

    CAS  PubMed  Google Scholar 

  21. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen B (2000) Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000(55):121–129

    Article  Google Scholar 

  22. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP (2001) SCC metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 50:55–63

    Article  CAS  PubMed  Google Scholar 

  23. Koivunen P, Laranne J, Virtaniemi J (2002) Cervical metastasis of unknown origin: a series of 72 patients. Acta Otolaryngol 122:569–574

    Article  PubMed  Google Scholar 

  24. Olu-Eddo A, Ohanaka C (2006) Peripheral lymphadenopathy in Nigerian adults. J Pak Med Assoc 56:405–408

    PubMed  Google Scholar 

  25. Oguz A, Karadenız C, Temel E, Citak E, Okur FV (2006) Evaluation of peripheral lymphadenopathy in children. Pediatr Hematol Oncol 23:549–561

    Article  PubMed  Google Scholar 

  26. Moor J, Murray P, Inwood J, Gouldesbrough D, Bem C (2008) Diagnostic biopsy of lymph nodes of the neck, axilla and groin: rhyme, reason or chance? Ann R Coll Surg Engl 90:221–225

    Article  PubMed Central  PubMed  Google Scholar 

  27. Bhatt J, Shah J, Shah F (2000) Clinico-pathological profile of cervical lymphadenopathy. J Appl Basic Med Sci 2:35–39

    Google Scholar 

  28. Jennsen C (2009) Clinical value of lymph node sonography. Praxis (Bern 1994) 98:581–588

    Article  Google Scholar 

  29. Ahuja A, Ying M (2005) Sonographic evaluation of cervical lymph nodes. AJR 184:1691–1699

    Article  PubMed  Google Scholar 

  30. Van den Brekel M, Castelijns J, Snow G (1998) The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? AJNR Am J Neuroradiol 19:695–700

    PubMed  Google Scholar 

  31. Steinkamp H, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R (1995) Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Brit J Radiol 68:266–270

    Article  CAS  PubMed  Google Scholar 

  32. Vassilakopoulos T, Pangalis G (2000) Application of a prediction rule to select which patients presenting with lymphadenopathy should undergo a lymph node biopsy. Medicine (Baltimore) 79:338–347

    Article  CAS  Google Scholar 

  33. Ying M, Ahuja A, Brook F, Brown B, Metreweli C (1996) Sonographic appearance and distribution of normal cervical lymph nodes in a Chinese population. J Ultrasound Med 15:431–436

    CAS  PubMed  Google Scholar 

  34. Kuna SK (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1538–1540

    Google Scholar 

  35. Steinkamp H, Beck A, Werk M, Rademaker J, Felix R (2003) Kapseldurchbrüche zervikaler Lymphknotenmetastasen: diagnostischer Stellenwert der Sonographie. Ultraschall Med 24:323–330

    Article  CAS  PubMed  Google Scholar 

  36. Ahuja A, Ying M (2003) Sonography of neck lymph nodes. Part II: abnormal lymph nodes. Clin Radiol 58:359–366

    Article  CAS  PubMed  Google Scholar 

  37. Moritz J, Ludwig A, Oestmann J (2000) Contrast-enhanced color Doppler sonography for evaluation of enlarged cervical lymph nodes in head and neck tumors. AJR Am J Roentgenol 174:1279–1284

    Article  CAS  PubMed  Google Scholar 

  38. Görg C, Hoffmann A (2008) Metastases to the Spleen in 59 cancer patients: a 14-year clinicosonographic study. Ultraschall Med 29(2):173–178

    Article  PubMed  Google Scholar 

  39. Shirakawa T, Miyamoto Y, Yamagishi J, Fukuda K, Tada S (2001) Color/power Doppler sonographic differential diagnosis of superficial lymphadenopathy: metastasis, malignant lymphoma, and benign process. J Ultrasound Med 20:525–532

    CAS  PubMed  Google Scholar 

  40. Erlinger T, Muntner P, Helzlsouer K (2004) WBC count and the risk of cancer mortality in a national sample of US adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomark Prev 13:1052–1056

    Google Scholar 

  41. Gunter M, Stolzenberg-Solomon R, Cross A, Leitzmann M, Weinstein S, Wood R et al (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 2006(66):2483–2487

    Article  Google Scholar 

  42. Baron J (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 37:1–24

    Article  CAS  PubMed  Google Scholar 

  43. Siemes C, Visser L, Coebergh J et al (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24:5216–5222

    Article  CAS  PubMed  Google Scholar 

  44. Gockel I, Dirksen K, Messow C, Junginger T (2006) Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol 12:3746–3750

    PubMed Central  CAS  PubMed  Google Scholar 

  45. Nozoe T, Saeki H, Ohga T, Sugimachi K (2002) Clinicopathological features of early esophageal squamous cell carcinoma with subsequent recurrence. Dis Esophagus 15:145–148

    Article  CAS  PubMed  Google Scholar 

  46. Motoyama S, Miura M, Hinai Y, Maruyama K et al (2009) CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer. Ann Surg Oncol 16:2479–2485

    Article  PubMed  Google Scholar 

  47. Khandavilli S, Ceallaigh P, Lloyd C, Whitaker R (2009) Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 45:912–914

    Article  CAS  PubMed  Google Scholar 

  48. Schneider W (1991) Thrombocytopenia as a threatening complication in tumor patients. J Lab Med 15:541–559

    Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the valuable contribution made by native English speaker Jane C. Crofts in correcting this manuscript.

Conflict of interest

None to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Basel Al Kadah.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al Kadah, B., Popov, H.H., Schick, B. et al. Cervical lymphadenopathy: study of 251 patients. Eur Arch Otorhinolaryngol 272, 745–752 (2015). https://doi.org/10.1007/s00405-014-3315-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-3315-9

Keywords

Navigation